These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 18468719

  • 1. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G, Hu X, Lu C, Su C, Luo S, Luo ZW.
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
    Zhang CY, Mao L, Li L, Tian Z, Zhou XJ, Zhang ZY, Li J.
    Cancer; 2007 Jul 01; 110(1):87-95. PubMed ID: 17520682
    [Abstract] [Full Text] [Related]

  • 3. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 4. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 5. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO, Toyooka S, Virmani AK, Sathyanarayana UG, Euhus DM, Gilcrease M, Minna JD, Gazdar AF.
    Cancer Res; 2001 Jun 01; 61(11):4556-60. PubMed ID: 11389090
    [Abstract] [Full Text] [Related]

  • 6. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma.
    Kikuchi S, Yamada D, Fukami T, Maruyama T, Ito A, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Cancer; 2006 Apr 15; 106(8):1751-8. PubMed ID: 16534787
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 8. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
    Kikuchi S, Yamada D, Fukami T, Masuda M, Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y, Onizuka M, Murakami Y.
    Clin Cancer Res; 2005 Apr 15; 11(8):2954-61. PubMed ID: 15837747
    [Abstract] [Full Text] [Related]

  • 9. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K.
    Oncol Rep; 2004 Aug 15; 12(2):389-95. PubMed ID: 15254707
    [Abstract] [Full Text] [Related]

  • 10. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH, Liu NH, Wang J, Bai H, Mao L.
    Chin Med J (Engl); 2008 Sep 05; 121(17):1712-21. PubMed ID: 19024105
    [Abstract] [Full Text] [Related]

  • 11. Hypermethylation of the GATA genes in lung cancer.
    Guo M, Akiyama Y, House MG, Hooker CM, Heath E, Gabrielson E, Yang SC, Han Y, Baylin SB, Herman JG, Brock MV.
    Clin Cancer Res; 2004 Dec 01; 10(23):7917-24. PubMed ID: 15585625
    [Abstract] [Full Text] [Related]

  • 12. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 01; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 13. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
    Ribeiro-Filho LA, Franks J, Sasaki M, Shiina H, Li LC, Nojima D, Arap S, Carroll P, Enokida H, Nakagawa M, Yonezawa S, Dahiya R.
    Mol Carcinog; 2002 Aug 01; 34(4):187-98. PubMed ID: 12203370
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 01; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 15. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF.
    Clin Cancer Res; 2001 Jul 01; 7(7):1998-2004. PubMed ID: 11448917
    [Abstract] [Full Text] [Related]

  • 16. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
    Chen JT, Cheng YW, Chou MC, Sen-Lin T, Lai WW, Ho WL, Lee H.
    Clin Cancer Res; 2003 Sep 15; 9(11):4200-4. PubMed ID: 14519646
    [Abstract] [Full Text] [Related]

  • 17. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS, Han J, Shim YM, Park J, Kim DH.
    Cancer; 2005 Nov 01; 104(9):1825-33. PubMed ID: 16177988
    [Abstract] [Full Text] [Related]

  • 18. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT, Jiao HL, Yang YL, Wang D, Zhang WM.
    Ai Zheng; 2007 Nov 01; 26(11):1199-203. PubMed ID: 17991318
    [Abstract] [Full Text] [Related]

  • 19. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z, Ren Y, Lin SX, Liang YJ, Liang HZ.
    Chin Med J (Engl); 2004 Aug 01; 117(8):1232-9. PubMed ID: 15361301
    [Abstract] [Full Text] [Related]

  • 20. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
    Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G.
    J Pathol; 2002 Dec 01; 198(4):442-9. PubMed ID: 12434413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.